A Study on the Association between Continuity of Care and High Risk Concomitant Medication in Continuous Non-steroidal Anti-inflammatory Drug Users

• Main Authors: Fan-Shiu Kao, 高凡修
• Other Authors: 林文德
• Format: Others
• Language: zh-TW
• Published: 2011
• Online Access: http://ndltd.ncl.edu.tw/handle/33288141443409602045

碩士 === 長榮大學 === 醫務管理學系(所) === 99 === Abstract Purpose : This study aimed to examine the association between continuity of care and high risk concomitant medication in continuous non-steroidal anti-inflammatory drug (NSAID) users. Methods: National Health Insurance (NHI) Research Database’s Longitudinal Health Insurance Database 2005 (LHID2005) were used to conducted this study. NHI’s beneficiaries with NSAID prescription more than 30 days in 2005 were defined as continous NSAID user, and their concomitant medications were defined as significant drug-drug interactions (DDI) event according to Drug Interaction Facts. Continuity of care (COC) index and usual provider continuity(UPC) were used to measure the continuity of care for continuous NSAID users. Multiple logistic regression analysis was then applied to estimate the association between continuity of care and high risk concomitant medication in continuous NSAID users. Results: There are 52,010(5.2%) people use NSAID more than 30 days in a year. 25 not have uses the high risk medicine; 20.2% had concomitant high risk medication. Medium and high (v. low) levels of continuity of care with high risk concomitant medication (adjusted rate ratio [RR] 0.89, 95% confidence interval [CI] 0.84- 0.94, and 0.76, 95% CI 0.71-0.80, respectively). Conclusions: This research discovery commonly used NSAID patient had higher continuity of care, and high-risk drugs combinations with significantly lower odds. Improving continuity of care should be an important part of future healthcare reform.